Open AccessCombination of PARP inhibitor and temozolomide to suppress chordoma progression
Author(s) -
Xiaoyu Cao,
Yanxin Lu,
Yang Liu,
Yiqiang Zhou,
Hua Song,
Wei Zhang,
Dionne Davis,
Jing Cui,
Shuyu Hao,
Jinkyu Jung,
Qixin Wu,
Deric M. Park,
Chunzhang Yang
Publication year - 2019
Publication title -
journal of molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.708
H-Index - 139
eISSN - 1432-1440
pISSN - 0946-2716
DOI - 10.1007/s00109-019-01802-z
Subject(s) - chordoma , temozolomide , olaparib , cancer research , parp inhibitor , poly adp ribose polymerase , in vivo , dna damage , cell cycle , medicine , cancer , biology , polymerase , pathology , dna , genetics , glioblastoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom